UBC researchers may have found a way to make donated blood universal
vancouversun.com
vancouversun.com
But we will still need to test for compatibility.
There are something like 28 different blood groups: Duffy, Kidd, Kell, etc.
People who have antibodies to those other blood groups can have a reaction even if given O negative blood.
(Source: I am board certified in Transfusion Medicine)
I'm the medical director for the blood bank of the only trauma center in an extremely remote location and a catchment of about 100,000 people. We operate our own donor center and do our own crossmatch (tube testing FTW!). We have 45 units of RBCs, 65 units of FFP, and 1 platelet unit for this evening. We also have 3 freezers full of frozen products and closely monitor our usage.
Obstetrics is probably the biggest user, but trauma may be the biggest in any given month. Our high water mark in recent history is 58 units of various products used for one patient a few months ago. We were nervous but got her through it without breaking quarantine to release product (although the quarantine units* were next on the agenda). We pushed 20 units a few days ago for a post-partum hemorrhage.
Quarantine in this case refers to units that have been produced but the infectious disease screening isn't complete yet, so we should not release them for use.
Please donate blood.
The majority of the population does not have antibodies to the other blood groups - the majority of the population is covered with the basic 4.
Blood group conversion (A, B, and AB to O) would be fantastic - it doesn't solve all the problems.
As stated elsewhere - please donate blood! A lot of the interesting things we do in medicine are predicated on blood availability: trauma, many obstetrics cases, cancer treatment, organ transplant (including bone marrow transplant), major surgeries, etc.
If you can't donate, encourage others to do so!
It's obviously early stage, but I'd absolutely love to see the Canadian Blood Service invest in lots of follow up studies to see how we can scale this technology.
Also, it's always great to see my alma mater on HN :)
Are there any advantages of using blood with the patient's specific antigen type over plain O-negative? Perhaps keeping all blood types available might still be a good idea in a hospital setting.
And there are lots of other less important blood factors. In most situations the donor blood is cross matched with the patient's blood, to directly test compatibility.
https://www.healthline.com/health/blood-typing-and-crossmatc...
Type O- is rare because being rhesus-negative is rare, but type O+ is quite common.
Rhesus negative had the problem of birth issues when their mothers had born rhesus positive elder siblings sadly.
[0] https://en.m.wikipedia.org/wiki/Hemolytic_disease_of_the_new...
> Withers and his team previously developed enzymes that were capable of stipping away antigens, but this new kind is much more powerful and efficient.
> An enzyme-driven process was first discovered in 1982 and research has carried on ever since.
> “The (1982) enzyme was incredibly inefficient,” he said. This newly-discovered enzyme is “thousands” times better.
> “The other big key: our enzyme works on whole blood,” he said. Previous research only worked on blood that had been broken down into component parts. With this new process, blood taken straight from donors could be quickly converted into type-O negative, without much delay.
> “If it all works it will have a big practical advantage.”
Wow, I didn't even know this was even mostly possible since the 80s. As exciting as this is, I suppose it's worth waiting and seeing if this is the one that makes it to production.
Researchers at the University of B.C. think they may have found a way to transform a very common type of human blood — type-A — in the universally usable type-O negative.
But, uh, I’d hope this tech would help prevent that sort of thing.
But... a huge proportion of all human health problems can be considered immunological problems: overactive immunity (transplant rejections, inflammation disorders like Crohn's) or impaired immunity (inability to recognize cancers, acquired deficiencies from infection i.e. AIDS, etc.).
One important thing to remember is that on an evolutionary time scale, the problems that arise from transfusion just started happening. There's been no time to select for them.
Instead, different blood types have different selective advantages that help maintain them, and incompatibility isn't sufficiently detrimental to offset those advantages.
There's an older paper from 2015 though: " Toward Efficient Enzymes For The Generation Of Universal Blood Through Structure-Guided Directed Evolution" https://pubs.acs.org/doi/abs/10.1021/ja5116088